For instance, according to one report, TGF-β1 treatment of T24 bladder cancer cells inhibited proliferation and viability while inducing apoptosis, which was linked with activation of the p38 MAPK-JNK-Caspase9/8/3 pathway [186]. Here, TGFB1 is linked to urinary bladder carcinoma.